2005
DOI: 10.1097/00054725-200502000-00015
|View full text |Cite
|
Sign up to set email alerts
|

Use of 6-Mercapturine/Azathioprine as the Immunomodulator of Choice for Moderately Active Crohnʼs Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 18 publications
(42 reference statements)
0
2
0
Order By: Relevance
“…The benefit of this approach is that corticosteroid use will be minimized, and the adverse effects of steroids on growth and bone development can be avoided. Others argue that uniformly giving 6‐MP will unnecessarily subject a considerable number of patients to a potent immunomodulatory drug 40,41. Hopefully, additional studies will identify the subset of patients that will benefit most from early initiation of 6‐MP.…”
Section: Lesson 5: 6‐mp/aza Therapy At the Onset Of Moderate To Severmentioning
confidence: 99%
See 1 more Smart Citation
“…The benefit of this approach is that corticosteroid use will be minimized, and the adverse effects of steroids on growth and bone development can be avoided. Others argue that uniformly giving 6‐MP will unnecessarily subject a considerable number of patients to a potent immunomodulatory drug 40,41. Hopefully, additional studies will identify the subset of patients that will benefit most from early initiation of 6‐MP.…”
Section: Lesson 5: 6‐mp/aza Therapy At the Onset Of Moderate To Severmentioning
confidence: 99%
“…Others argue that uniformly giving 6-MP will unnecessarily subject a considerable number of patients to a potent immunomodulatory drug. 40,41 Hopefully, additional studies will identify the subset of patients that will benefit most from early initiation of 6-MP.…”
Section: Lesson 5: 6-mp/aza Therapy At the Onset Of Moderate To Severmentioning
confidence: 99%